Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation

被引:19
作者
Marmont, AM [1 ]
Gualandi, F
van Lint, MT
Guastoni, C
Bacigalupo, A
机构
[1] S Martinos Hosp, Div Haematol, Genoa, Italy
[2] S Martinos Hosp, Stem Cell & Transplantat Ctr, Genoa, Italy
[3] Osped Civile, Div Nephrol, Legnano, Italy
基金
美国国家卫生研究院;
关键词
autologous stem cell transplantation; lupus nephritis; nephrotic syndrome;
D O I
10.1191/0961203306lu2241cr
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Autologous haematopoietic stem cell transplantation has become an accepted powerful therapeutic procedure for patients with severe, intractable SLE. Here we describe a 26-year old patient with stage IV-G diffuse global proliferative lupus nephritis and refractory nephrotic syndrome who responded to autologous peripheral stem cell transplantation (ASCT) after two mobilization procedures. Five years later the patient is in complete clinical and immunologic remission. The indications for ASCT and its mechanism of action are briefly discussed.
引用
收藏
页码:44 / 46
页数:3
相关论文
共 14 条
[1]
Collection of hematopoietic stem cells from patients with autoimmune diseases [J].
Burt, RK ;
Fassas, A ;
Snowden, JA ;
van Laar, JM ;
Kozak, T ;
Wulffraat, NM ;
Nash, RA ;
Dunbar, CE ;
Arnold, R ;
Prentice, G ;
Bingham, S ;
Marmont, AM ;
McSweeney, PA .
BONE MARROW TRANSPLANTATION, 2001, 28 (01) :1-12
[2]
Autologous hematopoietic stem cell transplantation for autoimmune diseases [J].
Gratwohl, A ;
Passweg, J ;
Bocelli-Tyndall, C ;
Fassas, A ;
van Laar, JM ;
Farge, D ;
Andolina, M ;
Arnold, R ;
Carreras, E ;
Finke, J ;
Kötter, I ;
Kozak, T ;
Lisukov, I ;
Löwenberg, B ;
Marmont, A ;
Moore, J ;
Saccardi, R ;
Snowden, JA ;
van den Hoogen, F ;
Wulffraat, NM ;
Zhao, XW ;
Tyndall, A .
BONE MARROW TRANSPLANTATION, 2005, 35 (09) :869-879
[3]
Gualandi F, 2005, BONE MARROW TRANSPL, V35, pS231
[4]
Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases [J].
Hinterberger, W ;
Hinterberger-Fischer, M ;
Marmont, A .
BONE MARROW TRANSPLANTATION, 2002, 30 (11) :753-759
[5]
Autologous stem cell transplantation for systemic lupus erythematosus [J].
Jayne, D ;
Passweg, J ;
Marmont, A ;
Farge, D ;
Zhao, XW ;
Arnold, R ;
Hiepe, F ;
Lisukov, I ;
Musso, M ;
Jian, OY ;
Marsh, J ;
Wulffraat, N ;
Besalduch, J ;
Bingham, SJ ;
Emery, P ;
Brune, M ;
Fassas, A ;
Faulkner, L ;
Ferster, A ;
Fiehn, C ;
Fouillard, L ;
Geromin, A ;
Greinix, H ;
Rabusin, M ;
Saccardi, R ;
Schneider, P ;
Zintl, F ;
Gratwohl, A ;
Tyndall, A .
LUPUS, 2004, 13 (03) :168-176
[6]
Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration [J].
Marmont, AM ;
vanLint, MT ;
Gualandi, F ;
Bacigalupo, A .
LUPUS, 1997, 6 (06) :545-548
[7]
IMMUNE ABLATION WITH STEM-CELL RESCUE - A POSSIBLE CURE FOR SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
MARMONT, AM .
LUPUS, 1993, 2 (03) :151-156
[8]
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients [J].
Muraro, PA ;
Douek, DC ;
Packer, A ;
Chung, K ;
Guenaga, FJ ;
Cassiani-Ingoni, R ;
Campbell, C ;
Memon, S ;
Nagle, JW ;
Hakim, FT ;
Gress, RE ;
McFarland, HF ;
Burt, RK ;
Martin, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :805-816
[9]
Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age [J].
Raiola, AM ;
Van Lint, MT ;
Lamparelli, T ;
Gualandi, F ;
Mordini, N ;
Berisso, G ;
Bregante, S ;
Frassoni, F ;
Sessarego, M ;
Fugazza, G ;
Di Stefano, F ;
Pitto, A ;
Bacigalupo, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (04) :716-721
[10]
STARKUTE L, 2005, BLOOD, V106, P2702